PEDIATRIC PSEUDOTUMOR CEREBRI SYNDROME IN A PREPUBERTAL NON-OBESE BOY: SILENT VISUAL IMPAIRMENT AND A NORMAL BRAIN MRI - A CASE REPORT

Bartosz Wójtowicz; Szymon Skrzypek; Patrycja Okoń; Jagoda Niczyporuk; Monika Zajączkowska; Ilona Owsiana; Magdalena  Chrościńska- Krawczyk

doi:10.31435/ijitss.3(51).2026.6422

Authors

Bartosz Wójtowicz Student Scientific Club of Pediatric Neurology, Medical University of Lublin, Poland https://orcid.org/0000-0002-7396-9117
Szymon Skrzypek Student Scientific Club of Pediatric Neurology, Medical University of Lublin, Poland https://orcid.org/0009-0009-9174-7786
Patrycja Okoń Student Scientific Club of Pediatric Neurology, Medical University of Lublin, Poland https://orcid.org/0009-0007-0988-5465
Jagoda Niczyporuk Student Scientific Club of Pediatric Neurology, Medical University of Lublin, Poland https://orcid.org/0009-0003-2035-5650
Monika Zajączkowska Student Scientific Club of Pediatric Neurology, Medical University of Lublin, Poland https://orcid.org/0000-0001-6545-4546
Ilona Owsiana Lek., Department of Child Neurology, Medical University of Lublin, Chodzki 2, 20-093 Lublin, Poland https://orcid.org/0000-0003-3154-5356
Magdalena Chrościńska- Krawczyk Dr hab. n. med., Department of Child Neurology, Medical University of Lublin, Chodzki 2, 20-093 Lublin, Poland https://orcid.org/0000-0001-8121-6580

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.6422

Keywords:

Pseudotumor Cerebri; Idiopathic Intracranial Hypertension; Papilledema

Abstract

Background: Pseudotumor cerebri syndrome (PTCS) is characterized by elevated intracranial pressure in the setting of normal cerebrospinal fluid composition and normal or typically altered neuroimaging, once secondary causes have been excluded. In adults the disease classically affects young obese women, but in children the demographic profile is more heterogeneous, with prepubertal patients frequently being non-obese and of either sex. Early recognition is essential because untreated PTCS can cause irreversible visual loss, yet the condition is easily overlooked when the clinical presentation deviates from the adult stereotype.

Case presentation: A 6-year-10-month-old prepubertal boy with a history of recurrent upper respiratory tract infections presented with a three-week history of abdominal pain, headache, vomiting, and double vision. Body mass index was 13.67 kg/m² (non-obese). Fundoscopy disclosed bilateral optic disc edema, and visual acuity was mildly reduced to 0.7 in the right eye and 0.5 in the left eye, although the child did not report visual symptoms. Magnetic resonance imaging of the brain, orbits, and whole spine was unremarkable, and computed tomography findings of low-lying cerebellar tonsils were not confirmed on MRI. Diagnostic lumbar puncture yielded clear, colorless cerebrospinal fluid with normal biochemistry and negative infectious and autoimmune workup. Acetazolamide, intravenous mannitol, and therapeutic lumbar puncture were followed by complete visual recovery (1.0 in each eye) and regression of papilledema within two weeks. Respiratory syncytial virus was treated with supportive care and amoxicillin-clavulanate because of suspected bacterial superinfection.

Discussion: This case illustrates three teaching points: PTCS must be considered in prepubertal non-obese children regardless of sex; visual impairment may develop silently and recover fully with prompt treatment; and a normal brain MRI does not exclude the diagnosis, which rests on the combination of clinical features, papilledema, cerebrospinal fluid findings, and exclusion of mimics.

Conclusion: Clinicians should maintain a low threshold for fundoscopy and lumbar puncture in any child with suggestive symptoms, irrespective of demographic profile, because timely treatment can prevent permanent visual loss even when the child does not report visual symptoms.

References

Aylward, S. C., & Reem, R. E. (2017). Pediatric intracranial hypertension. Pediatric Neurology, 66, 32–43. https://doi.org/10.1016/j.pediatrneurol.2016.08.010

Dandy, W. E. (1937). Intracranial pressure without brain tumor: Diagnosis and treatment. Annals of Surgery, 106(4), 492–513. https://doi.org/10.1097/00000658-193710000-00002

Friedman, D. I., Liu, G. T., & Digre, K. B. (2013). Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology, 81(13), 1159–1165. https://doi.org/10.1212/WNL.0b013e3182a55f17

Foley, J. (1955). Benign forms of intracranial hypertension; toxic and otitic hydrocephalus. Brain, 78(1), 1–41. https://doi.org/10.1093/brain/78.1.1

Smith, J. L. (1985). Whence pseudotumor cerebri? Journal of Clinical Neuro-Ophthalmology, 5(1), 55–56.

Barmherzig, R., & Szperka, C. L. (2019). Pseudotumor cerebri syndrome in children. Current Pain and Headache Reports, 23(8), Article 58. https://doi.org/10.1007/s11916-019-0795-8

Rangwala, L. M., & Liu, G. T. (2007). Pediatric idiopathic intracranial hypertension. Survey of Ophthalmology, 52(6), 597–617. https://doi.org/10.1016/j.survophthal.2007.08.018

Rook, B. S., & Phillips, P. H. (2016). Pediatric pseudotumor cerebri. Current Opinion in Ophthalmology, 27(5), 416–419. https://doi.org/10.1097/ICU.0000000000000300

Masri, A., Al Jaberi, M., Shihadat, R., Rayyan, A., AlMasri, M., Abuna’meh, L., Ali, M., Al Ryalat, N., Hadidy, A., & Al-Shakkah, A. A. (2022). Pseudotumor cerebri syndrome in children: Clinical characteristic and re-classification. Brain & Development, 44(7), 446–453. https://doi.org/10.1016/j.braindev.2022.03.006

Shah, S., Khan, A., Khan, M., & Lakshmanan, R. (2024). Paediatric idiopathic intracranial hypertension: Epidemiology, clinical features and treatment outcomes in a tertiary care centre in Western Australia. Journal of Paediatrics and Child Health, 60(10), 499–504. https://doi.org/10.1111/jpc.16622

Gillson, N., Jones, C., Reem, R. E., Rogers, D. L., Zumberge, N., & Aylward, S. C. (2017). Incidence and demographics of pediatric intracranial hypertension. Pediatric Neurology, 73, 42–47. https://doi.org/10.1016/j.pediatrneurol.2017.04.021

Beres, S. J. (2020). Update in pediatric pseudotumor cerebri syndrome. Seminars in Neurology, 40(3), 286–293. https://doi.org/10.1055/s-0040-1708847

Macher, S., Marik, W., Krajnc, N., Mitsch, C., Michl, M., Mueller, N., Novak, K., Zaic, S., Woeber, C., Pemp, B., & Bsteh, G. (2024). The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI—An external validation study. The Journal of Headache and Pain, 25(1), Article 70. https://doi.org/10.1186/s10194-024-01781-8

Heidary, G. (2026). Update on pediatric idiopathic intracranial hypertension. International Ophthalmology Clinics, 66(2), 64–67. https://doi.org/10.1097/IIO.0000000000000617

Sheldon, C. A., Reggie, S. N., Paley, G. L., McCormack, S. E., & Liu, G. T. (2022). Effects of acetazolamide on linear growth in children with pseudotumor cerebri syndrome. Frontiers in Ophthalmology, 2, Article 1042529. https://doi.org/10.3389/fopht.2022.1042529

Jeon-Chapman, J., Estrela, T., Heidary, G., & Gise, R. (2024). Efficacy and side effects of topiramate in treatment of children with pseudotumor cerebri syndrome. Pediatric Neurology, 160, 32–37. https://doi.org/10.1016/j.pediatrneurol.2024.06.015

Kilic, K., Korsbak, J. J., Jensen, R. H., & Cvetkovic, V. V. (2022). Diagnosis of idiopathic intracranial hypertension—The importance of excluding secondary causes: A systematic review. Cephalalgia, 42(6), 524–541. https://doi.org/10.1177/03331024211056580